Pathophysiology of ANCA-associated small vessel vasculitis

Current Rheumatology Reports

Volumn 12, Issue 6, 2010, Pages 399-405

  Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA; ANCA associated vasculitis; Animal models; Antineutrophil cytoplasmic autoantibodies; Churg Strauss syndrome; FimH; hLAMP 2 autoantibodies; Microscopic polyangiitis; MPO ANCA; Myeloperoxidase; Necrotizing crescentic glomerulonephritis; PR3 ANCA; Proteinase 3; Staphylococcus aureus; T regulatory cells; Th17 cells; Wegener's granulomatosis

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; INTERLEUKIN 17; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RITUXIMAB;

ANCA ASSOCIATED VASCULITIS; B LYMPHOCYTE; CELLULAR IMMUNITY; CHURG STRAUSS SYNDROME; CLINICAL OBSERVATION; CLINICAL TRIAL; COMPLEMENT ALTERNATIVE PATHWAY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFICACY; ENDOTHELIUM; ENDOTHELIUM CELL; EXPERIMENTAL STUDY; GRAM NEGATIVE BACTERIUM; GRANULOMATOUS INFLAMMATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYSIS; MICROSCOPIC POLYANGIITIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; WEGENER GRANULOMATOSIS;

EID: 77958107408     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-010-0138-6     Document Type: Review

References (48)

1. CG Kallenberg P Heeringa CA Stegeman 2006 Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides Nat Clin Pract Rheumatol 2 661 670 1:CAS:528:DC%2BD28XhtlentL3I 10.1038/ncprheum0355 17133251 (Pubitemid 44830855)
2. CGM Kallenberg 2005 Churg-Strauss syndrome: just one disease entity? Arthritis Rheum 52 2589 2593 10.1002/art.21253 16142739 (Pubitemid 41369085)
3. MM Boomsma CA Stegeman MJ van der Leij, et al. 2000 Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study Arthritis Rheum 43 2025 2033 1:STN:280:DC%2BD3cvmt1ejsw%3D%3D 10.1002/1529-0131(200009)43:9<2025::AID- ANR13>3.0.CO;2-O 11014352
4. JD Finkielman PA Merkel D Schroeder, et al. 2007 Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis Ann Intern Med 147 611 619 17975183
5. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group 2005 Etanercept plus standard therapy for Wegener's granulomatosis N Engl J Med 352 351 361 10.1056/NEJMoa041884
6. CA Stegeman JW Cohen Tervaert WJ Sluiter, et al. 1994 Association of nasal carriage of Staphylococcus aureus and higher relapse in Wegener's granulomatosis Ann Intern Med 120 12 17 1:STN:280:DyaK2c%2FntFehsw%3D%3D 8250451
7. JS Sanders MC Slot CA Stegeman 2003 Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 2072 2073 1:CAS:528:DC%2BD3sXptFKls7o%3D 10.1056/NEJM200311203492116 14627795 (Pubitemid 37448933)
8. JH Stone PA Merkel R Spiera, et al. 2010 Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 221 232 1:CAS:528:DC%2BC3cXptVKru78%3D 10.1056/NEJMoa0909905 20647199 This large randomized controlled trial demonstrated that rituximab is as effective as oral cyclophosphamide for induction of remission in patients with severe ANCA-associated vasculitis and could even be more effective than oral cyclophosphamide in relapsing patients. Given the long-term toxicity of oral cyclophosphamide, the results of this study may change current practice in the treatment of ANCA-associated vasculitis.
9. RB Jones JW Cohen Tervaert T Hauser, et al. 2010 Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis N Engl J Med 363 211 220 1:CAS:528:DC%2BC3cXptVKhs7c%3D 10.1056/NEJMoa0909169 20647198 This study showed that rituximab is as effective as pulse intravenous cyclophosphamide in patients with ANCA-associated vasculitis with severe renal involvement. It confirms and extends the data from the study by Stone et al. [8•] and suggests that rituximab could be first choice for induction treatment of ANCA-associated vasculitis
10. PJ Bansal MC Tobin 2004 Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement Ann Allergy Asthma Immunol 93 398 401 10.1016/S1081-1206(10)61400-7 15521377
11. RJ Falk R Terrell LA Charles JC Jennette 1990 Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals Proc Natl Acad Sci U S A 87 4115 4119 1:CAS:528:DyaK3cXktlylu7w%3D 10.1073/pnas.87.11.4115 2161532 (Pubitemid 20217992)
12. AA Rarok PC Limburg CGM Kallenberg 2003 Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies J Leukoc Biol 74 3 15 1:CAS:528:DC%2BD3sXlsVeqt74%3D 10.1189/jlb.1202611 12832437 (Pubitemid 38040431)
13. A Schreiber S Rolle L Peripelittchenko, et al. 2010 Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis Kidney Int 77 118 128 1:CAS:528:DC%2BC3cXjs1Wj 10.1038/ki.2009.420 19907415 This study is built on prior observations that ANCA-induced neutrophil activation is a fundamental pathophysiologic mechanism in MPO-ANCA-associated vasculitis. Interfering in this mechanism by blocking the action of the enzyme phosphoinositol 3-kinase-γ inhibited the development of disease in an animal model of MPO-ANCA-associated glomerulonephritis. Inhibitors of this enzyme, which have been developed, could be used in clinical practice
14. A Schreiber H Xiao JC Jennette, et al. 2009 C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis J Am Soc Nephrol 20 289 298 1:CAS:528:DC%2BD1MXjtFCrt7Y%3D 10.1681/ASN.2008050497 19073822 Blocking the interaction between complement C5a and its receptor could abrogate lesion development in an animal model of MPO-ANCA glomerulonephritis. As monoclonal antibodies to C5a are clinically available, interfering in this process could be a novel treatment of ANCA-associated vasculitis
15. GQ Xing M Chen G Liu, et al. 2009 Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis J Clin Immunol 29 282 291 1:CAS:528:DC%2BD1MXlslCnt7Y%3D 10.1007/s10875-008-9268-2 19067130
16. BH Ewert JC Jennette RJ Falk 1992 Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells Kidney Int 41 375 383 1:CAS:528:DyaK38XkvVyntL8%3D 10.1038/ki.1992.52 1313124
17. DJ Radford CO Savage GB Nash 2000 Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion Arthritis Rheum 43 1337 1345 1:CAS:528: DC%2BD3cXkvFWnu7w%3D 10.1002/1529-0131(200006)43:6<1337::AID-ANR16>3.0. CO;2-M 10857792 (Pubitemid 30416318)
18. SL Nolan N Kalia GB Nash, et al. 2008 Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo J Am Soc Nephrol 19 973 984 1:CAS:528:DC%2BD1cXmtlOgs7g%3D 10.1681/ASN.2007111166 18305123
19. K Kessenbrock M Krumbholz U Schönermarck, et al. 2009 Netting neutrophils in autoimmune small-vessel vasculitis Nat Med 15 623 625 1:CAS:528:DC%2BD1MXmtVOrtrY%3D 10.1038/nm.1959 19448636 The authors present a new mechanism for the pathogenic role of ANCA-induced neutrophil activation. The antibodies induce formation of NETs. These NETs containing PR3 and MPO may not only trigger vasculitis in the kidneys but may also promote the autoimmune response to PR3 and MPO
20. H Xiao P Heeringa P Hu, et al. 2002 Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice J Clin Invest 110 955 963 1:CAS:528:DC%2BD38XnslSksbg%3D 12370273
21. D Huugen H Xiao A van Esch, et al. 2005 Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha Am J Pathol 167 47 58 1:CAS:528:DC%2BD2MXms1eisbs%3D 15972951
22. H Xiao P Heeringa Z Liu, et al. 2005 The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies Am J Pathol 167 39 45 1:CAS:528:DC%2BD2MXms1eisbo%3D 15972950
23. A Schreiber H Xiao RJ Falk JC Jennette 2006 Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies J Am Soc Nephrol 17 3355 3364 10.1681/ASN.2006070718 17108314 (Pubitemid 44865278)
24. H Xiao A Schreiber P Heeringa, et al. 2007 Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies Am J Pathol 170 52 64 1:CAS:528:DC%2BD2sXhsV2gtbk%3D 10.2353/ajpath.2007.060573 17200182 (Pubitemid 47339189)
25. MM van Timmeren BS van der Veen CA Stegeman, et al. 2010 IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis J Am Soc Nephrol 21 1103 1114 10.1681/ASN.2009090984 20448018 The authors showed that modulation of IgG glycosylation with the bacterial enzyme Endo S can prevent induction and mitigate disease expression in an animal model of MPO-ANCA-associated glomerulonephritis. This could be a potential new approach in the treatment of ANCA-associated vasculitis
26. MA Little CL Smyth R Yadav, et al. 2005 Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo Blood 106 2050 2058 1:CAS:528:DC%2BD2MXhtVWksLrI 10.1182/blood-2005-03-0921 15933057 (Pubitemid 41291719)
27. H Pfister M Ollert LF Fröhlich, et al. 2004 Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo Blood 104 1411 1418 1:CAS:528: DC%2BD2cXnt1ersrg%3D 10.1182/blood-2004-01-0267 15150076 (Pubitemid 39166519)
28. YM van der Geld T Hellmark D Selga, et al. 2007 Rats and mice immunized with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes Ann Rheum Dis 66 1679 1682 10.1136/ard.2006.064626 17644551 (Pubitemid 350205462)
29. WF Pendergraft 3rd GA Preston RR Shah, et al. 2004 Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3 Nat Med 10 72 79 1:CAS:528:DC%2BD2cXlsFCl 10.1038/nm968 14661018 (Pubitemid 38524701)
30. JM Yang DJ Bautz S Lionaki, et al. 2008 ANCA patients have T cells responsive to complementary PR-3 antigen Kidney Int 74 1159 1169 1:CAS:528:DC%2BD1cXht1CmsbfI 10.1038/ki.2008.309 18596726
31. R Kain M Exner R Brandes, et al. 2008 Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis Nat Med 14 1088 1096 1:CAS:528: DC%2BD1cXht1Slu7rL 10.1038/nm.1874 18836458 The authors presented a new autoantibody directed to hLAMP-2 in pauci-immune necrotizing glomerulonephritis that is highly sensitive and specific for this condition. Most interestingly, they showed that immunization with an adhesion from gram-negative bacteria, by molecular mimicry, induces antibodies to hLAMP-2 that were pathogenic in in vitro and in vivo experiments
32. R Kain K Matsui M Exner, et al. 1995 A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-LAMP-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells J Exp Med 181 585 597 1:CAS:528:DyaK2MXjtFyhu7c%3D 10.1084/jem.181.2.585 7836914
33. CG Kallenberg CA Stegeman P Heeringa 2008 Autoantibodies vex the vasculature Nat Med 14 1018 1019 1:CAS:528:DC%2BD1cXht1Slu73K 10.1038/nm1008-1018 18841136
34. Holle JU, Gross WL, Holl-Ulrich K, et al.: Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 2010 May 28 (Epub ahead of print).
35. WH Abdulahad YM van der Geld CA Stegeman CG Kallenberg 2006 Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis Kidney Int 70 938 947 1:CAS:528:DC%2BD28XosVOmt7o%3D 10.1038/sj.ki.5001670 16837919 (Pubitemid 44285972)
36. P Lamprecht S Wieczorek JT Epplen, et al. 2009 Granuloma formation in ANCA-associated vasculitides APMIS Suppl 127 32 36 1:CAS:528:DC%2BD1MXhtValsrnF 10.1111/j.1600-0463.2009.02474.x 19515137
37. + effector memory cells are present in the urine of patients with active renal involvement in ANCA-associated vasculitis. This may enable a diagnosis of active renal disease in this condition without doing a renal biopsy
38. WH Abdulahad CA Stegeman PC Limburg CG Kallenberg 2008 Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission Arthritis Rheum 58 2196 2205 10.1002/art.23557 18576340 (Pubitemid 351988114)
39. E Nogueira S Hamour D Sawant, et al. 2010 Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis Nephrol Dial Transplant 25 2209 2217 1:CAS:528:DC%2BC3cXotFehtb0%3D 10.1093/ndt/gfp783 20100727
40. PY Gan OM Steinmetz DS Tan, et al. 2010 Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis J Am Soc Nephrol 21 925 931 1:CAS:528:DC%2BC3cXot1Grurk%3D 10.1681/ASN.2009070763 20299361 Th17 cells have been proposed as major effector cells in autoimmune disease. Here, the authors showed that IL-17A is instrumental in the pathophysiology of experimental MPO-ANCA glomerulonephritis. Targeting IL-17 may be a promising approach
41. + T cells can predict prognosis in patients with ANCA-associated vasculitis and SLE. This may allow a more individualized therapeutic approach in patients with these diseases
42. WH Abdulahad CA Stegeman YM van der Geld, et al. 2007 Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission Arthritis Rheum 56 2080 2091 1:CAS:528:DC%2BD2sXnsVOgs7w%3D 10.1002/art.22692 17530650 (Pubitemid 47110408)
43. MD Morgan CJ Day KP Piper, et al. 2010 Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells Immunology 130 64 73 1:CAS:528:DC%2BC3cXlt1Kntrs%3D 10.1111/j.1365-2567.2009.03213.x 20113371
44. S Wieczorek JU Holle JT Epplen 2010 Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome Curr Opin Rheumatol 22 8 14 1:CAS:528:DC%2BD1MXhsVyqsrnJ 10.1097/BOR.0b013e3283331151 19864953
45. SL Hogan GS Cooper DA Savitz, et al. 2007 Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study Clin J Am Soc Nephrol 2 290 299 10.2215/CJN.03501006 17699427
46. CA Stegeman JW Cohen Tervaert PE de Jong CGM Kallenberg 1996 Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group N Engl J Med 335 16 20 1:CAS:528:DyaK28Xkslamsr0%3D 10.1056/NEJM199607043350103 8637536 (Pubitemid 26230808)
47. ER Popa CA Stegeman CGM Kallenberg JW Cohen Tervaert 2002 Staphylococcus aureus and Wegener's granulomatosus Arthritis Res 4 77 79 10.1186/ar392 11879541 (Pubitemid 34257339)
48. WH Abdulahad CA Stegeman CGM Kallenberg 2009 The role of CD4+ T cells in ANCA-associated systemic vasculitis Nephrology 14 26 32 1:CAS:528: DC%2BD1MXlslChsrc%3D 10.1111/j.1440-1797.2008.01069.x 19143940